Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amifostine in the management of radiation-induced and chemo-induced mucositis.

Literature DB >> 16586122

Amifostine in the management of radiation-induced and chemo-induced mucositis.

Rene-Jean Bensadoun¹, Mark M Schubert, Rajesh V Lalla, Dorothy Keefe.

Abstract

INTRODUCTION: Mucositis is a significant complication of cancer therapy, with important clinical and economic implications. In June 2005, the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) conducted an evidence-based update review of the literature on mucositis. The goal of this literature review is to update previously published guidelines for the management of mucositis.
RESULTS: This article reports the findings of the subgroup charged with reviewing the literature related to amifostine.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2006 PMID： 16586122 DOI： 10.1007/s00520-006-0047-4

Source DB: PubMed Journal: Support Care Cancer ISSN： 0941-4355 Impact factor: 3.603

40 in total

1. Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma--a phase II study.

Authors: Ernst Späth-Schwalbe; Catalina Lange; Isabelle Genvresse; Larissa Krüger; Jan Eucker; Markus Schweigert; Orhan Sezer; Volker Budach; Kurt Possinger
Journal: Anticancer Drugs Date: 2002-04 Impact factor: 2.248

2. A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients.

Authors: E Jantunen; T Kuittinen; T Nousiainen
Journal: Leuk Lymphoma Date: 2002-10

3. Rating the quality of evidence for clinical practice guidelines.

Authors: D C Hadorn; D Baker; J S Hodges; N Hicks
Journal: J Clin Epidemiol Date: 1996-07 Impact factor: 6.437

4. Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer.

Authors: Dosia Antonadou; Marizenia Pepelassi; Maria Synodinou; Maria Puglisi; Nicolas Throuvalas
Journal: Int J Radiat Oncol Biol Phys Date: 2002-03-01 Impact factor: 7.038

5. Intrarectal application of amifostine for the prevention of radiation-induced rectal injury.

Authors: Edgar Ben-Josef; Sue Han; Martin Tobi; Barbara J Vargas; Beth Stamos; Laura Kelly; Sandra Biggar; Irving Kaplan
Journal: Semin Radiat Oncol Date: 2002-01 Impact factor: 5.934

6. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.

Authors: Benjamin Movsas; Charles Scott; Corey Langer; Maria Werner-Wasik; Nicos Nicolaou; Ritsuko Komaki; Mitchell Machtay; Colum Smith; Rita Axelrod; Linda Sarna; Todd Wasserman; Roger Byhardt
Journal: J Clin Oncol Date: 2005-04-01 Impact factor: 44.544

7. Cytoprotective effect of amifostine in radiation-induced acute mucositis - a retrospective analysis.

Authors: J Kouvaris; V Kouloulias; J Kokakis; G Matsopoulos; M Balafouta; A Miliadou; L Vlahos
Journal: Onkologie Date: 2002-08

8. Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma.

Authors: Robert Myerson; Imran Zobeiri; Elisa Birnbaum; David Dietz; James Fleshman; Ira Kodner; Joel Picus; Gary Ratkin
Journal: Semin Oncol Date: 2002-12 Impact factor: 4.929

9. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors: Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal: Cancer Date: 2004-05-01 Impact factor: 6.860

Review 10. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

Authors: Andy Trotti; Lisa A Bellm; Joel B Epstein; Diana Frame; Henry J Fuchs; Clement K Gwede; Eugene Komaroff; Luba Nalysnyk; Marya D Zilberberg
Journal: Radiother Oncol Date: 2003-03 Impact factor: 6.280

12 in total

1. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.

Authors: D E Peterson; R-J Bensadoun; F Roila
Journal: Ann Oncol Date: 2011-09 Impact factor: 32.976

2. The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles.

Authors: Rajesh V Lalla
Journal: Support Care Cancer Date: 2012-11-17 Impact factor: 3.603

Review 3. Palliative dental care- a boon for debilitating.

Authors: Bhavana Sujana Mulk; Raja Lakshmi Chintamaneni; Prabhat Mpv; Sarat Gummadapu; Shyam Sundar Salvadhi
Journal: J Clin Diagn Res Date: 2014-06-20

Review 4. Systematic review of amifostine for the management of oral mucositis in cancer patients.

Authors: Ourania Nicolatou-Galitis; Triantafyllia Sarri; Joanne Bowen; Mario Di Palma; Vassilios E Kouloulias; Pasquale Niscola; Dorothea Riesenbeck; Monique Stokman; Wim Tissing; Eric Yeoh; Sharon Elad; Rajesh V Lalla
Journal: Support Care Cancer Date: 2012-10-03 Impact factor: 3.603

5. Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastases.

Authors: Guillaume Peyraga; Delphine Caron; Thibaut Lizee; Yann Metayer; Anne-Lise Septans; Yoann Pointreau; Fabrice Denis; Gerard Ganem; Cedrik Lafond; Sophie Roche; Olivier Dupuis
Journal: Support Care Cancer Date: 2017-12-23 Impact factor: 3.603